Analysis of RhoC expression and lymphovascular emboli in inflammatory vs non-inflammatory breast cancers in Egyptian patients

An Chi Lo, Ageliki Georgopoulos, Celina G. Kleer, Mousumi Banerjee, Sherif Omar, Hussein Khaled, Saad Eissa, Ahmed Hablas, Hoda G. Omar, Julie A. Douglas, Sofia D. Merajver, Amr S. Soliman

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Understanding the molecular factors that distinguish inflammatory breast cancer (IBC) from non-IBC is important for IBC diagnosis. We reviewed the records of 48 IBC patients and 64 non-IBC patients from Egypt. We determined RhoC expression and tumor emboli and their relationship to demographic and reproductive characteristics. Compared with non-IBC patients, IBC patients had significantly lower parity (P = 0.018) and fewer palpable tumors (P < 0.0001). IBC tumors showed RhoC overexpression more frequently than non-IBC tumors (87% vs. 17%, respectively) (P < 0.0001). Tumor emboli were significantly more frequent in IBC tumors than non-IBC tumors (Mean ± SD: 14.1 ± 14.0 vs. 7.0 ± 12.9, respectively) (P < 0.0001). This study illustrates that RhoC overexpression and tumor emboli are more frequent in tumors of IBC relative to non-IBC from Egypt. Future studies should focus on relating epidemiologic factors to molecular features of IBC in this population.

Original languageEnglish (US)
Pages (from-to)55-59
Number of pages5
JournalBreast
Volume18
Issue number1
DOIs
StatePublished - Feb 2009

Fingerprint

Inflammatory Breast Neoplasms
Embolism
Breast Neoplasms
Egypt
Neoplasms
Epidemiologic Factors
Parity
Demography

Keywords

  • Developing countries
  • Egypt
  • Inflammatory breast cancer
  • RhoC
  • Tumor emboli

ASJC Scopus subject areas

  • Surgery

Cite this

Lo, A. C., Georgopoulos, A., Kleer, C. G., Banerjee, M., Omar, S., Khaled, H., ... Soliman, A. S. (2009). Analysis of RhoC expression and lymphovascular emboli in inflammatory vs non-inflammatory breast cancers in Egyptian patients. Breast, 18(1), 55-59. https://doi.org/10.1016/j.breast.2008.11.002

Analysis of RhoC expression and lymphovascular emboli in inflammatory vs non-inflammatory breast cancers in Egyptian patients. / Lo, An Chi; Georgopoulos, Ageliki; Kleer, Celina G.; Banerjee, Mousumi; Omar, Sherif; Khaled, Hussein; Eissa, Saad; Hablas, Ahmed; Omar, Hoda G.; Douglas, Julie A.; Merajver, Sofia D.; Soliman, Amr S.

In: Breast, Vol. 18, No. 1, 02.2009, p. 55-59.

Research output: Contribution to journalArticle

Lo, AC, Georgopoulos, A, Kleer, CG, Banerjee, M, Omar, S, Khaled, H, Eissa, S, Hablas, A, Omar, HG, Douglas, JA, Merajver, SD & Soliman, AS 2009, 'Analysis of RhoC expression and lymphovascular emboli in inflammatory vs non-inflammatory breast cancers in Egyptian patients', Breast, vol. 18, no. 1, pp. 55-59. https://doi.org/10.1016/j.breast.2008.11.002
Lo, An Chi ; Georgopoulos, Ageliki ; Kleer, Celina G. ; Banerjee, Mousumi ; Omar, Sherif ; Khaled, Hussein ; Eissa, Saad ; Hablas, Ahmed ; Omar, Hoda G. ; Douglas, Julie A. ; Merajver, Sofia D. ; Soliman, Amr S. / Analysis of RhoC expression and lymphovascular emboli in inflammatory vs non-inflammatory breast cancers in Egyptian patients. In: Breast. 2009 ; Vol. 18, No. 1. pp. 55-59.
@article{4cfb15481b624c0d80af141fe16e6661,
title = "Analysis of RhoC expression and lymphovascular emboli in inflammatory vs non-inflammatory breast cancers in Egyptian patients",
abstract = "Understanding the molecular factors that distinguish inflammatory breast cancer (IBC) from non-IBC is important for IBC diagnosis. We reviewed the records of 48 IBC patients and 64 non-IBC patients from Egypt. We determined RhoC expression and tumor emboli and their relationship to demographic and reproductive characteristics. Compared with non-IBC patients, IBC patients had significantly lower parity (P = 0.018) and fewer palpable tumors (P < 0.0001). IBC tumors showed RhoC overexpression more frequently than non-IBC tumors (87{\%} vs. 17{\%}, respectively) (P < 0.0001). Tumor emboli were significantly more frequent in IBC tumors than non-IBC tumors (Mean ± SD: 14.1 ± 14.0 vs. 7.0 ± 12.9, respectively) (P < 0.0001). This study illustrates that RhoC overexpression and tumor emboli are more frequent in tumors of IBC relative to non-IBC from Egypt. Future studies should focus on relating epidemiologic factors to molecular features of IBC in this population.",
keywords = "Developing countries, Egypt, Inflammatory breast cancer, RhoC, Tumor emboli",
author = "Lo, {An Chi} and Ageliki Georgopoulos and Kleer, {Celina G.} and Mousumi Banerjee and Sherif Omar and Hussein Khaled and Saad Eissa and Ahmed Hablas and Omar, {Hoda G.} and Douglas, {Julie A.} and Merajver, {Sofia D.} and Soliman, {Amr S.}",
year = "2009",
month = "2",
doi = "10.1016/j.breast.2008.11.002",
language = "English (US)",
volume = "18",
pages = "55--59",
journal = "Breast",
issn = "0960-9776",
publisher = "Churchill Livingstone",
number = "1",

}

TY - JOUR

T1 - Analysis of RhoC expression and lymphovascular emboli in inflammatory vs non-inflammatory breast cancers in Egyptian patients

AU - Lo, An Chi

AU - Georgopoulos, Ageliki

AU - Kleer, Celina G.

AU - Banerjee, Mousumi

AU - Omar, Sherif

AU - Khaled, Hussein

AU - Eissa, Saad

AU - Hablas, Ahmed

AU - Omar, Hoda G.

AU - Douglas, Julie A.

AU - Merajver, Sofia D.

AU - Soliman, Amr S.

PY - 2009/2

Y1 - 2009/2

N2 - Understanding the molecular factors that distinguish inflammatory breast cancer (IBC) from non-IBC is important for IBC diagnosis. We reviewed the records of 48 IBC patients and 64 non-IBC patients from Egypt. We determined RhoC expression and tumor emboli and their relationship to demographic and reproductive characteristics. Compared with non-IBC patients, IBC patients had significantly lower parity (P = 0.018) and fewer palpable tumors (P < 0.0001). IBC tumors showed RhoC overexpression more frequently than non-IBC tumors (87% vs. 17%, respectively) (P < 0.0001). Tumor emboli were significantly more frequent in IBC tumors than non-IBC tumors (Mean ± SD: 14.1 ± 14.0 vs. 7.0 ± 12.9, respectively) (P < 0.0001). This study illustrates that RhoC overexpression and tumor emboli are more frequent in tumors of IBC relative to non-IBC from Egypt. Future studies should focus on relating epidemiologic factors to molecular features of IBC in this population.

AB - Understanding the molecular factors that distinguish inflammatory breast cancer (IBC) from non-IBC is important for IBC diagnosis. We reviewed the records of 48 IBC patients and 64 non-IBC patients from Egypt. We determined RhoC expression and tumor emboli and their relationship to demographic and reproductive characteristics. Compared with non-IBC patients, IBC patients had significantly lower parity (P = 0.018) and fewer palpable tumors (P < 0.0001). IBC tumors showed RhoC overexpression more frequently than non-IBC tumors (87% vs. 17%, respectively) (P < 0.0001). Tumor emboli were significantly more frequent in IBC tumors than non-IBC tumors (Mean ± SD: 14.1 ± 14.0 vs. 7.0 ± 12.9, respectively) (P < 0.0001). This study illustrates that RhoC overexpression and tumor emboli are more frequent in tumors of IBC relative to non-IBC from Egypt. Future studies should focus on relating epidemiologic factors to molecular features of IBC in this population.

KW - Developing countries

KW - Egypt

KW - Inflammatory breast cancer

KW - RhoC

KW - Tumor emboli

UR - http://www.scopus.com/inward/record.url?scp=59849106355&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59849106355&partnerID=8YFLogxK

U2 - 10.1016/j.breast.2008.11.002

DO - 10.1016/j.breast.2008.11.002

M3 - Article

C2 - 19157876

AN - SCOPUS:59849106355

VL - 18

SP - 55

EP - 59

JO - Breast

JF - Breast

SN - 0960-9776

IS - 1

ER -